文献速递其他结缔组织病

欧洲多中心研究验证ELF检测作为系统性硬化症纤维化生物标志物

European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

结果显示ELF评分及组分在dcSSc和男性中更高,与mRSS、疾病活动度、严重度相关,与FVC%、TLC%、DLCO%呈负相关;多因素分析显示年龄、mRSS和DLCO%与ELF评分独立相关。

要点

  • ELF评分及TIMP-1、PIIINP在dcSSc和男性SSc患者中升高。
  • ELF评分及组分与mRSS、疾病活动度和严重度相关,与FVC%、TLC%、DLCO%呈负相关。
  • 年龄、mRSS和DLCO%与ELF评分独立相关。

核心结论

  • ELF评分作为SSc皮肤和肺受累的独立标志物,在首项研究和本验证研究共457例患者中得到确认。

主要发现

  • ELF评分、TIMP-1和PIIINP水平在男性中更高(分别为P=0.0197、P=0.0107、P=0.0108)。
  • ELF评分、TIMP-1和PIIINP水平在dcSSc中更高(分别为P=0.001、P=0.0008、P<0.0001)。
  • ELF评分及单一标志物与mRSS显著相关(r=0.37,P<0.0001)。
  • ELF评分及标志物与疾病活动和严重度相关(除HA为P=0.0001外,其余标志物均P<0.0001)。
  • TIMP-1与FVC%负相关(r=-0.21,P=0.0012),PIIINP与FVC%负相关(r=-0.26,P=0.0001);ELF评分与TLC%负相关(r=-0.20,P=0.0036),TIMP-1与TLC%负相关(r=-0.32,P<0.0001),PIIINP与TLC%负相关(r=-0.28,P<0.0001);所有标志物与DLCO%相关(除HA为P=0.0115外,其余均P<0.0001)。

关键数值与推荐

  • ELF评分、TIMP-1、PIIINP在男性中较高(P值分别为0.0197、0.0107、0.0108)。
  • ELF评分、TIMP-1、PIIINP在dcSSc中较高(P值分别为0.001、0.0008、P<0.0001)。
  • ELF评分及单一标志物与mRSS相关(r=0.37,P<0.0001)。
  • TIMP-1与FVC%相关(r=-0.21,P=0.0012),PIIINP与FVC%相关(r=-0.26,P=0.0001)。
  • 年龄、mRSS和DLCO%与ELF评分独立相关(P值分别为<0.001、<0.001、0.005)。

临床怎么用

  • ELF评分及其组分可作为评估SSc皮肤和肺纤维化受累的血清生物标志物,尤其适用于dcSSc和男性患者。
  • 结合mRSS和DLCO%可辅助解读ELF评分,用于识别皮肤和肺受累较重的SSc患者。

局限性

  • 本研究为横断面验证分析,尚不能确定ELF评分对皮肤和肺进展的预测价值。
  • 原文提到正在开展纵向研究以建立具有预测价值的SSc特异性算法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To validate enhanced liver fibrosis (ELF) test and its components-amino-terminal propeptide of procollagen type III (PIIINP), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) and HA-as biomarkers of fibrosis in SSc in an independent, international, multicentre cohort. METHODS: Two hundred and fifty-four SSc patients from six Rheumatology Centres were included. Sera were collected and stored according to EUSTAR biobanking recommendations and analysed through automated high throughput diagnostics. Statistical analysis was performed with SPSS software. RESULTS: Two hundred and forty-seven SSc patients (mean age 55.7 ± 13.9 years, 202 F) were analysed. ELF score, TIMP-1 and PIIINP levels were higher in males (P = 0.0197, P = 0.0107, P = 0.0108 respectively) and in dcSSc (P = 0.001, P = 0.0008, P < 0.0001 respectively). ELF score and the single markers significantly correlated with modified Rodnan skin score (r = 0.37, P < 0.0001), disease activity and severity (P < 0.0001 for all markers, except for HA P = 0.0001) and inversely with forced vital capacity, (FVC) % (TIMP-1, r = -0.21, P = 0.0012; PIIINP, r = -0.26, P = 0.0001), TLC% (ELF score, r = -0.20, P = 0.0036; TIMP-1, r = -0.32, P < 0.0001; PIIINP, r = -0.28, P < 0.0001), diffusion capacity of the lung for carbon monoxide (DLCO) % (P < 0.0001 for all markers, except for HA P = 0.0115). Multivariate analysis indicated that age (P < 0.001), modified Rodnan skin score (P < 0.001) and DLCO% (P = 0.005) were independently associated with ELF score. CONCLUSION: Between the first and this validation studies, the value of the ELF score as independent marker of skin and lung involvement in SSc is confirmed in 457 patients. A longitudinal study is on-going to identify an SSc specific algorithm with predictive value for skin and lung progression.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Abignano G, Blagojevic J, Bissell LA, et al. European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology (Oxford). 2019. PMID: 30239834. doi:10.1093/rheumatology/key271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。